HK Stock Market Move | CSTONE PHARMA-B (02616) rose over 11% in the afternoon; the company plans to initiate the global Phase III registrational clinical trial of CS2009 by the end of 2026.
CSTONE PHARMA-B (02616) rose over 11% in the afternoon. As of press time, it was up 11.17% at HK$6.07, with a turnover of HK$56.2713 million.
CSTONE PHARMA-B (02616) rose over 11% in the afternoon. As of press time, it was up 11.17% at HK$6.07, with a turnover of HK$56.2713 million.
On the news front, CSTONE PHARMA announced the latest clinical data for its PD-1/VEGF/CTLA-4 trispecific antibody CS2009 at the 2026 ESMO Congress, with safety maintaining a favorable profile and excellent efficacy demonstrated across first-line NSCLC, later-line NSCLC, and 1L mCRC indications. The company plans to initiate the first batch of global multicenter registrational Phase III clinical trials for CS2009 by the end of 2026, and is in discussions with multiple multinational pharmaceutical companies regarding potential collaborations to accelerate the global development of CS2009.
In addition, CSTONE PHARMA recently announced a collaboration with Kimia. The two parties will jointly advance the clinical development of a solid tumor drug candidate with first-in-class potential targeting the DNA damage response (DDR) pathway critical to solid tumor survival. CSTONE PHARMA will share in the global commercial value of this first-in-class drug through milestone payments and sales royalties.
Related Articles

BofA Securities: Maintains "Buy" Rating on BYD COMPANY (01211); Management Remains Optimistic About Domestic Market Outlook

Self-defined innovation sets a new paradigm for battery safety: Aurora Battery highlights BAIC MOTOR (01958) delivering a new "answer" for family-oriented all-terrain driving.
.png)
HK Stock Market Move | |JW THERAP-B (02126) Rebounds Over 8%; Company Clarifies Cost Dispute, Expects Unit Production Cost of Benlysta to Drop Over 65% Starting Next Year
BofA Securities: Maintains "Buy" Rating on BYD COMPANY (01211); Management Remains Optimistic About Domestic Market Outlook

Self-defined innovation sets a new paradigm for battery safety: Aurora Battery highlights BAIC MOTOR (01958) delivering a new "answer" for family-oriented all-terrain driving.

HK Stock Market Move | |JW THERAP-B (02126) Rebounds Over 8%; Company Clarifies Cost Dispute, Expects Unit Production Cost of Benlysta to Drop Over 65% Starting Next Year
.png)





